Pharmacokinetics and tissue distribution of anidulafungin in rats

被引：46

作者：

Damle, Bharat ^{[1
]}

Stogniew, Martin ^{[2
]}

Dowei, James ^{[2
]}

机构：

[1] Pfizer Inc, Clin Pharmacol, Global Res & Dev, New York, NY 10017 USA

[2] Vicuron Pharmaceut, New York, NY USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2008年 / 52卷 / 07期

关键词：

D O I：

10.1128/AAC.01596-07

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

This study assessed the tissue distribution of anidulafungin in rats. Anidulafungin rapidly distributed into tissues, achieving peak concentrations within 30 min, and maintained levels above MICs for common pathogens over 72 h. In tissues susceptible to fungal infection (liver, lung, spleen, kidney), exposure was 9- to 12-fold higher than in plasma.

引用

页码：2673 / 2676

页数：4

共 20 条

[1] Pharmacology of systemic antifungal agents
Ashley, Elizabeth S. Dodds
Lewis, Russell
Lewis, James S.
Martin, Craig
Andes, David
[J]. CLINICAL INFECTIOUS DISEASES, 2006, 43 : S28 - S39
[2] DOWELL J, 2003, 43 INT C ANT AG CHEM
[3] Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts
Espinel-Ingroff, A
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (10) : 2950 - 2956
[4] Once-weekly micafungin therapy is as effective as daily therapy for disseminated candidiasis in mice with persistent neutropenia
Gumbo, Tawanda
Drusano, George L.
Liu, Weiguo
Kulawy, Robert W.
Fregeau, Christine
Hsu, Vasha
Louie, Arnold
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (03) : 968 - 974
[5] Anidulafungin pharmacokinetics and microbial response in neutropenic mice with disseminated candidiasis
Gumbo, Tawanda
Drusano, George L.
Liu, Weiguo
Ma, Lei
Deziel, Mark R.
Drusano, Michael F.
Louie, Arnold
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (11) : 3695 - 3700
[6] AUTORADIOGRAPHY USING STORAGE PHOSPHOR TECHNOLOGY
JOHNSTON, RF
PICKETT, SC
BARKER, DL
[J]. ELECTROPHORESIS, 1990, 11 (05) : 355 - 360
[7] A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis
Krause, DS
Simjee, AE
van Rensburg, C
Viljoen, J
Walsh, TJ
Goldstein, BP
Wible, M
Henkel, T
[J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 (06) : 770 - 775
[8] Pharmacodynamics of caspofungin in a murine model of systemic candidiasis: Importance of persistence of caspofungin in tissues to understanding drug activity
Louie, A
Deziel, M
Liu, WG
Drusano, MF
Gumbo, T
Drusano, GL
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (12) : 5058 - 5068
[9] MOORE CB, 2002, 42 INT C ANT AG CHEM
[10] Tissue distribution after intravenous dosing of micafungin, an antifungal drug, to rats
Niwa, T
Yokota, Y
Tokunaga, A
Yamato, Y
Kagayama, A
Fujiwara, T
Hatakeyama, J
Anezaki, M
Ohtsuka, Y
Takagi, A
[J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (07) : 1154 - 1156

← 1 2 →